» Articles » PMID: 36653409

Brain Activity During A working Memory Task After Daily Caffeine Intake and Caffeine Withdrawal: a Randomized Double-blind Placebo-controlled Trial

Overview
Journal Sci Rep
Specialty Science
Date 2023 Jan 18
PMID 36653409
Authors
Affiliations
Soon will be listed here.
Abstract

Acute caffeine intake has been found to increase working memory (WM)-related brain activity in healthy adults without improving behavioral performances. The impact of daily caffeine intake-a ritual shared by 80% of the population worldwide-and of its discontinuation on working memory and its neural correlates remained unknown. In this double-blind, randomized, crossover study, we examined working memory functions in 20 young healthy non-smokers (age: 26.4 ± 4.0 years; body mass index: 22.7 ± 1.4 kg/m; and habitual caffeine intake: 474.1 ± 107.5 mg/day) in a 10-day caffeine (150 mg × 3 times/day), a 10-day placebo (3 times/day), and a withdrawal condition (9-day caffeine followed by 1-day placebo). Throughout the 10th day of each condition, participants performed four times a working memory task (N-Back, comprising 3- and 0-back), and task-related blood-oxygen-level-dependent (BOLD) activity was measured in the last session with functional magnetic resonance imaging. Compared to placebo, participants showed a higher error rate and a longer reaction time in 3- against 0-back trials in the caffeine condition; also, in the withdrawal condition we observed a higher error rate compared to placebo. However, task-related BOLD activity, i.e., an increased attention network and decreased default mode network activity in 3- versus 0-back, did not show significant differences among three conditions. Interestingly, irrespective of 3- or 0-back, BOLD activity was reduced in the right hippocampus in the caffeine condition compared to placebo. Adding to the earlier evidence showing increasing cerebral metabolic demands for WM function after acute caffeine intake, our data suggest that such demands might be impeded over daily intake and therefore result in a worse performance. Finally, the reduced hippocampal activity may reflect caffeine-associated hippocampal grey matter plasticity reported in the previous analysis. The findings of this study reveal an adapted neurocognitive response to daily caffeine exposure and highlight the importance of classifying impacts of caffeine on clinical and healthy populations.

Citing Articles

Dissociable Contributions of Goal-Relevant Evidence and Goal-Irrelevant Familiarity to Individual and Developmental Differences in Conflict Recognition.

Weigard A, Suzuki T, Skalaban L, Conley M, Cohen A, Garavan H Cogn Sci. 2024; 48(11):e70019.

PMID: 39587984 PMC: 11589665. DOI: 10.1111/cogs.70019.


Brain dysfunctions and neurotoxicity induced by psychostimulants in experimental models and humans: an overview of recent findings.

Serra M, Simola N, Pollack A, Costa G Neural Regen Res. 2024; 19(9):1908-1918.

PMID: 38227515 PMC: 11040293. DOI: 10.4103/1673-5374.390971.


The effects of caffeine and d-amphetamine on spatial span task in healthy participants.

Kassim F, Lim J, Slawik S, Gaus K, Peters B, Lee J PLoS One. 2023; 18(7):e0287538.

PMID: 37440493 PMC: 10343048. DOI: 10.1371/journal.pone.0287538.


Relationship between Habitual Caffeine Consumption, Attentional Performance, and Individual Alpha Frequency during Total Sleep Deprivation.

Quiquempoix M, Drogou C, Erblang M, VAN Beers P, Guillard M, Tardo-Dino P Int J Environ Res Public Health. 2023; 20(6).

PMID: 36981883 PMC: 10049386. DOI: 10.3390/ijerph20064971.

References
1.
Clark K, Squire R, Merrikhi Y, Noudoost B . Visual attention: Linking prefrontal sources to neuronal and behavioral correlates. Prog Neurobiol. 2015; 132:59-80. DOI: 10.1016/j.pneurobio.2015.06.006. View

2.
Sakata M, Ishibashi K, Imai M, Wagatsuma K, Ishii K, Zhou X . Initial Evaluation of an Adenosine A Receptor Ligand, C-Preladenant, in Healthy Human Subjects. J Nucl Med. 2017; 58(9):1464-1470. DOI: 10.2967/jnumed.116.188474. View

3.
Mohd Zulkifly M, Merkohitaj O, Paulus W . Transcranial alternating current stimulation induced excitatory aftereffects are abolished by decaffeinated espresso and reversed into inhibition by espresso with caffeine. Clin Neurophysiol. 2020; 131(3):778-779. DOI: 10.1016/j.clinph.2019.11.062. View

4.
Prediger R . Effects of caffeine in Parkinson's disease: from neuroprotection to the management of motor and non-motor symptoms. J Alzheimers Dis. 2010; 20 Suppl 1:S205-20. DOI: 10.3233/JAD-2010-091459. View

5.
Varani K, Portaluppi F, Merighi S, Ongini E, Belardinelli L, Borea P . Caffeine alters A2A adenosine receptors and their function in human platelets. Circulation. 1999; 99(19):2499-502. DOI: 10.1161/01.cir.99.19.2499. View